Table of Content

Executive Summary
Scope and Definition

1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Rise of At-Home Colorectal Cancer Screening
1.1.2 Multimodal Approaches to Colorectal Cancer Screening
1.1.3 Use of Gut Microbiota in Colorectal Cancer Diagnosis
1.2 Research and Development Review
1.2.1 Patent Filing Trend (by Country, by Year)
1.3 Impact Analysis for Key Global Events: COVID-19
1.3.1 Pre-COVID-19 Phase
1.3.2 During-COVID-19 Phase
1.3.3 Post-COVID-19 Phase
1.4 Product Pipeline
1.5 Regulatory Landscape
1.6 Reimbursement Scenarios in Different Countries and Regions
1.6.1 Stool DNA Test
1.6.2 Fecal Immunochemical Test (FIT)
1.6.3 Fecal Occult Blood Test (FOBT)
1.6.4 Colonoscopies and Sigmoidoscopies
1.6.5 Biomarker Tests
1.7 Pricing Analysis for Different Test Types in Different Regions
1.8 Market Dynamics Overview
1.8.1 Market Drivers
1.8.1.1 Rising Incidence of Colorectal Cancer and Increasing Financial Burden on Healthcare
1.8.1.2 Growing Demand for Colorectal Cancer Testing
1.8.1.3 Advances in Genomics and Molecular Diagnostics
1.8.1.4 Earlier Cancer Detection Enabling Reduced Treatment Cost
1.8.2 Market Restraints
1.8.2.1 Limited Sensitivity of FIT/FOBT Testing Kits
1.8.2.2 Challenges with Sample Collection
1.8.3 Market Opportunities
1.8.3.1 Expansion of Screening Programs
1.8.3.2 Markets Proposing Significant Untapped Potential

2 Application
2.1 Application Segmentation
2.2 Application Summary
2.2.1 Application Summary
2.2.2 End User Summary
2.2.2.1 Analyst View
2.3 Global Colorectal Cancer Screening and Diagnostics Market (by End User)
2.4 Overview
2.4.1 Hospitals and Clinics
2.4.2 Ambulatory Centers
2.4.3 Clinical Laboratories
2.4.4 Others

3 Products
3.1 Product Segmentation
3.2 Product Summary
3.2.1 Analyst View
3.3 Global Colorectal Cancer Screening and Diagnostics Market (by Type)
3.3.1 Market Overview
3.3.2 Stool DNA Test
3.3.2.1 Pricing Analysis
3.3.2.2 Competitive Analysis
3.3.2.3 Test Volume
3.3.2.4 Market Sizing and Forecast
3.3.3 Fecal Immunochemical Test (FIT)
3.3.3.1 Pricing Analysis
3.3.3.2 Competitive Analysis
3.3.3.3 Test Volume
3.3.3.4 Market Sizing and Forecast
3.3.4 Fecal Occult Blood Test (FOBT)
3.3.4.1 Pricing Analysis
3.3.4.2 Competitive Analysis
3.3.4.3 Test Volume
3.3.4.4 Market Sizing and Forecast
3.3.5 Colonoscopies and Sigmoidoscopies
3.3.5.1 Pricing Analysis
3.3.5.2 Test Volume
3.3.5.3 Market Sizing and Forecast
3.3.6 Biomarkers Test
3.3.6.1 Pricing Analysis
3.3.6.2 Competitive Analysis
3.3.6.3 Test Volume
3.3.6.4 Market Sizing and Forecast

4 Region
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 Test Volume
4.3.8 Market Sizing and Forecast
4.3.9 Canada
4.3.10 Test Volume
4.3.11 Market Sizing and Forecast
4.4 Europe
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.4 Application
4.4.5 Product
4.4.6 France
4.4.7 Driving Factors for Market Growth
4.4.8 Factors Challenging the Market
4.4.9 Test Volume
4.4.10 Market Sizing and Forecast
4.4.11 Germany
4.4.12 Driving Factors for Market Growth
4.4.13 Factors Challenging the Market
4.4.14 Test Volume
4.4.15 Market Sizing and Forecast
4.4.16 U.K.
4.4.17 Driving Factors for Market Growth
4.4.18 Factors Challenging the Market
4.4.19 Test Volume
4.4.20 Market Sizing and Forecast
4.4.21 Spain
4.4.22 Driving Factors for Market Growth
4.4.23 Factors Challenging the Market
4.4.24 Test Volume
4.4.25 Market Sizing and Forecast
4.4.26 Italy
4.4.27 Driving Factors for Market Growth
4.4.28 Factors Challenging the Market
4.4.29 Test Volume
4.4.30 Market Sizing and Forecast
4.4.31 Rest-of-Europe
4.4.32 Driving Factors for Market Growth
4.4.33 Factors Challenging the Market
4.4.34 Test Volume
4.4.35 Market Sizing and Forecast
4.5 Asia-Pacific
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.4 Application
4.5.5 Product
4.5.6 China
4.5.7 Driving Factors for Market Growth
4.5.8 Factors Challenging the Market
4.5.9 Test Volume
4.5.10 Market Sizing and Forecast
4.5.11 India
4.5.12 Driving Factors for Market Growth
4.5.13 Factors Challenging the Market
4.5.14 Test Volume
4.5.15 Market Sizing and Forecast
4.5.16 Australia
4.5.17 Driving Factors for Market Growth
4.5.18 Factors Challenging the Market
4.5.19 Test Volume
4.5.20 Market Sizing and Forecast
4.5.21 Japan
4.5.22 Driving Factors for Market Growth
4.5.23 Factors Challenging the Market
4.5.24 Test Volume
4.5.25 Market Sizing and Forecast
4.5.26 South Korea
4.5.27 Driving Factors for Market Growth
4.5.28 Factors Challenging the Market
4.5.29 Test Volume
4.5.30 Market Sizing and Forecast
4.5.31 Rest-of-Asia-Pacific
4.5.32 Driving Factors for Market Growth
4.5.33 Factors Challenging the Market
4.5.34 Test Volume
4.5.35 Market Sizing and Forecast
4.6 Latin America
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.4 Application
4.6.5 Product
4.6.6 Brazil
4.6.7 Driving Factors for Market Growth
4.6.8 Factors Challenging the Market
4.6.9 Test Volume
4.6.10 Market Sizing and Forecast
4.6.11 Mexico
4.6.12 Driving Factors for Market Growth
4.6.13 Factors Challenging the Market
4.6.14 Test Volume
4.6.15 Market Sizing and Forecast
4.6.16 Rest-of-Latin America
4.6.17 Driving Factors for Market Growth
4.6.18 Factors Challenging the Market
4.6.19 Test Volume
4.6.20 Market Sizing and Forecast
4.7 Middle East and Africa
4.7.1 Regional Overview
4.7.2 Driving Factors for Market Growth
4.7.3 Factors Challenging the Market
4.7.4 Application
4.7.5 Product
4.7.6 U.A.E.
4.7.7 Driving Factors for Market Growth
4.7.8 Factors Challenging the Market
4.7.9 Test Volume
4.7.10 Market Sizing and Forecast
4.7.11 South Africa
4.7.12 Driving Factors for Market Growth
4.7.13 Factors Challenging the Market
4.7.14 Test Volume
4.7.15 Market Sizing and Forecast
4.7.16 Rest-of-Middle East and Africa
4.7.17 Driving Factors for Market Growth
4.7.18 Factors Challenging the Market
4.7.19 Test Volume
4.7.20 Market Sizing and Forecast
5 Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers
5.2 Geographic Assessment
5.2.1 DiaCarta, Inc.
5.2.1.1 Overview
5.2.1.2 Top Products/Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Key Personnel
5.2.1.5 Analyst View
5.2.2 Danaher Corporation
5.2.2.1 Overview
5.2.2.2 Top Products/Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Key Personnel
5.2.2.5 Analyst View
5.2.3 Epigenomics AG
5.2.3.1 Overview
5.2.3.2 Top Products/Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Key Personnel
5.2.3.5 Analyst View
5.2.4 Eiken Chemical Co., Ltd.
5.2.4.1 Overview
5.2.4.2 Top Products/Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Key Personnel
5.2.4.5 Analyst View
5.2.5 Exact Sciences Corporation
5.2.5.1 Overview
5.2.5.2 Top Products/Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Key Personnel
5.2.5.5 Analyst View
5.2.6 Freenome Holdings, Inc.
5.2.6.1 Overview
5.2.6.2 Top Products/Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Key Personnel
5.2.6.5 Analyst View
5.2.7 FUJIFILM Holdings Corporation
5.2.7.1 Overview
5.2.7.2 Top Products/Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Key Personnel
5.2.7.5 Analyst View
5.2.8 Guardant Health, Inc.
5.2.8.1 Overview
5.2.8.2 Top Products/Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Key Personnel
5.2.8.5 Analyst View
5.2.9 Lepu Medical Technology (Beijing) Co., Ltd.
5.2.9.1 Overview
5.2.9.2 Top Products/Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Key Personnel
5.2.9.5 Analyst View
5.2.10 Mainz Biomed NV
5.2.10.1 Overview
5.2.10.2 Top Products/Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Key Personnel
5.2.10.5 Analyst View
5.2.11 New Horizon Health
5.2.11.1 Overview
5.2.11.2 Top Products/Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Key Personnel
5.2.11.5 Analyst View
5.2.12 Novigenix SA
5.2.12.1 Overview
5.2.12.2 Top Products/Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Key Personnel
5.2.12.5 Analyst View
5.2.13 Prenetics Global Limited
5.2.13.1 Overview
5.2.13.2 Top Products/Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Key Personnel
5.2.13.5 Analyst View
5.2.14 Olympus Corporation
5.2.14.1 Overview
5.2.14.2 Top Products/Product Portfolio
5.2.14.3 Top Competitors
5.2.14.4 Key Personnel
5.2.14.5 Analyst View
5.2.15 HOYA Corporation
5.2.15.1 Overview
5.2.15.2 Top Products/Product Portfolio
5.2.15.3 Top Competitors
5.2.15.4 Key Personnel
5.2.15.5 Analyst View
5.2.16 QuidelOrtho Corporation
5.2.16.1 Overview
5.2.16.2 Top Products/Product Portfolio
5.2.16.3 Top Competitors
5.2.16.4 Key Personnel
5.2.16.5 Analyst View

6 Research Methodology
6.1 Data Sources
6.1.1 Primary Data Sources
6.1.2 Secondary Data Sources
6.1.3 Data Triangulation
6.2 Market Estimation and Forecast
List of Figures
Figure 1: Global Colorectal Cancer Screening and Diagnostics Market, $Million, 2023, 2026, and 2033
Figure 2: Global Colorectal Cancer Screening and Diagnostics Market (by Region), $Million, 2022, 2026, and 2033
Figure 3: Global Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022, 2026, and 2033
Figure 4: Global Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022, 2026, and 2033
Figure 5: Key Events to Keep Track of within the Colorectal Cancer Screening and Diagnostics Market
Figure 6: Global Colorectal Cancer Screening and Diagnostics Market (by Country), January 2021-December 2023
Figure 7: Global Colorectal Cancer Screening and Diagnostics Market (by Year), January 2021-December 2023
Figure 8: Colorectal Cancer Cases Diagnosed and Colonoscopies Performed (Pre-Pandemic And During Pandemic), Aragon Spain, March 2020-February 2021
Figure 9: Number of Colorectal Cancer Cases Globally, 2020- 2040
Figure 10: Uptake of FIT Test, U.K., 2019-2022
Figure 11: Cancer Survival Rate with Respect to Stage of Detection, 2022
Figure 12: Stool DNA Test Colorectal Cancer Screening and Diagnostics Market, Competitive Analysis
Figure 13: Stool DNA Test Colorectal Cancer Screening and Diagnostics Market, Test Volume, Unit Thousands, 2022-2033
Figure 14: Stool DNA Test Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 15: FIT Colorectal Cancer Screening and Diagnostics Market, Competitive Analysis
Figure 16: Fecal Immunochemical Test Colorectal Cancer Screening and Diagnostics Market, Test Volume, Unit Thousands, 2022-2033
Figure 17: Fecal Immunochemical Test Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 18: FOBT Colorectal Cancer Screening and Diagnostics Market, Competitive Analysis
Figure 19: Fecal Occult Blood Test Colorectal Cancer Screening and Diagnostics Market, Test Volume, Unit Thousands, 2022-2033
Figure 20: Fecal Occult Blood Test Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 21: Colonoscopies and Sigmoido Test Colorectal Cancer Screening and Diagnostics Market, Test Volume, Unit Thousands, 2022-2033
Figure 22: Colonoscopy and Sigmoidoscopy Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 23: Biomarker Test Colorectal Cancer Screening and Diagnostics Market, Test Volume, Unit Thousands, 2022-2033
Figure 24: Biomarker Tests Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 25: U.S. Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 26: Canada Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 27: France Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 28: Germany Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 29: U.K. Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 30: Spain Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 31: Italy Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 32: Rest-of-Europe Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 33: China Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 34: India Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 35: Australia Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 36: Japan Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 37: South Korea Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 38: Rest-of-Asia-Pacific Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 39: Brazil Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 40: Mexico Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 41: Rest-of-Latin America Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 42: U.A.E. Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 43: South Africa Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 44: Rest-of-Middle East and Africa Colorectal Cancer Screening and Diagnostics Market, $Million, 2022-2033
Figure 45: Strategic Initiatives, 2020-2024
Figure 46: Share of Strategic Initiatives, 2020-2024
Figure 47: Data Triangulation
Figure 48: Top-Down and Bottom-Up Approach
Figure 49: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Global Colorectal Cancer Screening and Diagnostics Market, Opportunities
Table 3: Colorectal Cancer Screening and Diagnostics Market Trend Analysis
Table 4: Examples of Gut Microbiotia as Biomarker for Colorectal Cancer Screening
Table 5: Global Colorectal Cancer Screening and Diagnostic Market, Product Pipeline
Table 6: Reimbursement of Stool DNA Test (by Country)
Table 7: Reimbursement of Fecal Immunochemical Test (by Country)
Table 8: Reimbursement of Fecal Occult Blood Test (by Country)
Table 9: Reimbursement of Colonoscopies and Sigmoidoscopies (by Country)
Table 10: Reimbursement of Biomarker Tests (by Country)
Table 11: Pricing Analysis for Different Test Types in Different Regions,($)
Table 12: Impact Analysis of Market Navigating Factors, 2023-2033
Table 13: Examples of Global Colorectal Cancer Screening Initiatives
Table 14: Examples of Product Launches and Approval in Asia-Pacific
Table 15: Global Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022-2033
Table 16: Global Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 17: Pricing Analysis for Stool DNA Test in Different Regions,($)
Table 18: Pricing Analysis for Different Fecal Immunochemical Test Different Regions,($)
Table 19: Pricing Analysis for Fecal Occult Blood Test in Different Regions,($)
Table 20: Pricing Analysis for Colonoscopies and Sigmoidoscopies in Different Regions,($)
Table 21: Pricing Analysis for Biomarker Test in Different Regions,($)
Table 22: Global Colorectal Cancer Screening and Diagnostics Market (by Region), $Million, 2022-2033
Table 23: North America Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022-2033
Table 24: North America Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 25: U.S. Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 26: U.S. Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 27: Canada Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 28: Canada Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 29: Europe Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022-2033
Table 30: Europe Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 31: France Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 32: France Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 33: Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 34: Germany Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 35: U.K. Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 36: U.K. Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 37: Spain Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 38: Spain Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 39: Italy Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 40: Italy Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 41: Rest-of-Europe Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Unit Thousands ), 2022-2033
Table 42: Rest-of-Europe Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 43: Asia-Pacific Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022-2033
Table 44: Asia-Pacific Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 45: China Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 46: China Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 47: India Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 48: India Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 49: Australia Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 50: Australia Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 51: Japan Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 52: Japan Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 53: South Korea Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 54: South Korea Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 55: Rest-of-Asia-Pacific Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 56: Rest-of-Asia-Pacific Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 57: Latin America Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022-2033
Table 58: Latin America Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 59: Brazil Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 60: Brazil Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 61: Mexico Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 62: Mexico Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 63: Rest-of-Latin America Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 64: Rest-of-Latin America Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 65: Middle East and Africa Colorectal Cancer Screening and Diagnostics Market (by End User), $Million, 2022-2033
Table 66: Middle East and Africa Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 67: U.A.E. Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 68: U.A.E. Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 69: South Africa Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 70: South Africa Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033
Table 71: Rest-of-Middle East and Africa Colorectal Cancer Screening and Diagnostics Market (by Type), Test Volume (Thousands), 2022-2033
Table 72: Rest-of-Middle East and Africa Colorectal Cancer Screening and Diagnostics Market (by Type), $Million, 2022-2033